These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 33274479)

  • 1. Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease: A pilot study.
    Gálvez-Romero JL; Palmeros-Rojas O; Real-Ramírez FA; Sánchez-Romero S; Tome-Maxil R; Ramírez-Sandoval MP; Olivos-Rodríguez R; Flores-Encarnación SE; Cabrera-Estrada AA; Ávila-Morales J; Cortés-Sánchez V; Sarmiento-Padilla G; Tezmol-Ramírez SE; Aparicio-Hernández D; Urbina-Sánchez MI; Gómez-Pluma MÁ; Cisneros-Méndez S; Rodríguez-Rivas DI; Reyes-Inurrigarro S; Cortés-Díaz G; Cruz-Delgado C; Navarro-González J; Deveaux-Homs J; Pedraza-Sánchez S
    J Intern Med; 2021 Jun; 289(6):906-920. PubMed ID: 33274479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia.
    Pinzón MA; Ortiz S; Holguín H; Betancur JF; Cardona Arango D; Laniado H; Arias Arias C; Muñoz B; Quiceno J; Jaramillo D; Ramirez Z
    PLoS One; 2021; 16(5):e0252057. PubMed ID: 34033648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
    Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M
    Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results with cyclosporine monotherapy in renal transplant patients: a multivariate analysis of risk factors.
    Montagnino G; Tarantino A; Maccario M; Elli A; Cesana B; Ponticelli C
    Am J Kidney Dis; 2000 Jun; 35(6):1135-43. PubMed ID: 10845828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
    Hoyer PF; Brodeh J
    J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for bullous pemphigoid.
    Singh S; Kirtschig G; Anchan VN; Chi CC; Taghipour K; Boyle RJ; Murrell DF
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD002292. PubMed ID: 37572360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus.
    Dammacco F; Della Casa Alberighi O; Ferraccioli G; Racanelli V; Casatta L; Bartoli E
    Int J Clin Lab Res; 2000; 30(2):67-73. PubMed ID: 11043499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical corticosteroids for dry eye.
    Liu SH; Saldanha IJ; Abraham AG; Rittiphairoj T; Hauswirth S; Gregory D; Ifantides C; Li T
    Cochrane Database Syst Rev; 2022 Oct; 10(10):CD015070. PubMed ID: 36269562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in signs and symptoms of severe dry eye disease after dual therapy with high-potency steroids and 0.05% cyclosporine.
    Lee CY; Chang LC; Chang CK; Lu PT; Huang JY; Yang SF; Sun CC
    Ann Med; 2024 Dec; 56(1):2391019. PubMed ID: 39155824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.
    Fernández-Cruz A; Ruiz-Antorán B; Muñoz-Gómez A; Sancho-López A; Mills-Sánchez P; Centeno-Soto GA; Blanco-Alonso S; Javaloyes-Garachana L; Galán-Gómez A; Valencia-Alijo Á; Gómez-Irusta J; Payares-Herrera C; Morrás-Torre I; Sánchez-Chica E; Delgado-Téllez-de-Cepeda L; Callejas-Díaz A; Ramos-Martínez A; Múñez-Rubio E; Avendaño-Solá C
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes.
    Burroughs TE; Lentine KL; Takemoto SK; Swindle J; Machnicki G; Hardinger K; Brennan DC; Irish WD; Schnitzler MA
    Clin J Am Soc Nephrol; 2007 May; 2(3):517-23. PubMed ID: 17699459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
    Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL;
    Kidney Int; 2001 Apr; 59(4):1484-90. PubMed ID: 11260412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of glucocorticoids alone and combined with cyclosporine a in patients with IgA nephropathy: a prospective randomized controlled trial.
    Liu H; Xu X; Fang Y; Ji J; Zhang X; Yuan M; Liu C; Ding X
    Intern Med; 2014; 53(7):675-81. PubMed ID: 24694475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.
    Gregory MJ; Smoyer WE; Sedman A; Kershaw DB; Valentini RP; Johnson K; Bunchman TE
    J Am Soc Nephrol; 1996 Apr; 7(4):543-9. PubMed ID: 8724887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M; Latter DA; Loertscher R
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.
    Borie R; Savale L; Dossier A; Ghosn J; Taillé C; Visseaux B; Jebreen K; Diallo A; Tesmoingt C; Morer L; Goletto T; Faucher N; Hajouji L; Neukirch C; Phillips M; Stelianides S; Bouadma L; Brosseau S; Ottaviani S; Pluvy J; Le Pluart D; Debray MP; Raynaud-Simon A; Descamps D; Khalil A; Timsit JF; Lescure FX; Descamps V; Papo T; Humbert M; Crestani B; Dieude P; Vicaut E; Zalcman G;
    PLoS One; 2020; 15(12):e0243961. PubMed ID: 33326457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.